Back to 
Envestnet Asset Management Inc.
Envestnet Asset Management Inc.
CRVS
Showing 0 of 10 quarters
Position history for Envestnet Asset Management Inc.'s holdings in Corvus Pharmaceuticals, Inc.
No. Envestnet Asset Management exited its CRVS (Corvus Pharmaceuticals) position in Q2 2023. Its Q1 2023 13F listed 10,500 shares worth $9,555. Envestnet Asset Management first reported CRVS in Q1 2021 and held it in 9 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.